Blog

/Blog
All Articles
June 21, 2019

Mary Meeker’s 2019 Internet Trends Report — What Pharma Marketers Need to Know

Mary Meeker, tech maven and founder of the newly formed Bond Capital -- and former partner at venture-capital firm Kleiner Perkins Caufield & Byers -- recently presented her latest internet trends report at Recode’s Code 2019 conference, and this one was nearly as large as the 2017 presentation. This recap highlights what’s relevant for pharma marketers.

June 12, 2019

Diversity and Inclusion – Is Your Brand Doing It Right?

Kick back with the television, a magazine, or some quality YouTube time, and you’re likely to see diversity and inclusion in many ads. Ideally, you’ll see differently abled people, interracial couples with biracial children, active seniors, same-sex couples, people of short stature, full-figured models, and friend groups that resemble the

June 10, 2019

Voice, the Next Generation

Earlier this year, we pondered whether voice search is simply a fad or whether it’s a trend we can’t go backward from, particularly as more and more people rely on their smart phones and speakers for answers to pressing questions. Our conclusion? “From basic accessibility to on-demand disease education and

June 6, 2019

Five Issues in Washington for Pharma to Watch

At the Coalition’s Rising Leaders conference on healthcare policy in Washington, D.C. May 22, a diverse set of speakers provided updates and predictions, and discussed the potential impact of the many significant healthcare policy decisions pending on Capitol Hill. This POV provides an overview of five issues to watch that were highlighted at the conference, as well as strategies for addressing them.

May 21, 2019

Sensitive Disease State Media Targeting

With the advancement of programmatic media in the pharmaceutical space, many types of targeting are available that can identify and serve pharma ads to the right audiences, both in direct-to-consumer (DTC) and healthcare provider (HCP) advertising. When putting together a media plan for a specific brand, it is important to consider the disease state sensitivity associated with the brand before aligning on targeting tactics.

May 16, 2019

New List Price Mandate for DTC Television Advertising

On May 8, 2019, the Trump administration announced that the Centers for Medicare & Medicaid Services (CMS) would require drugs covered by Medicare or Medicaid to include a list price in any DTC television commercial within 60 days of the announcement, if their list price is at least $35 for a month’s supply or a course of treatment. The ruling is virtually the same as the one proposed in October 2018, and only products that advertise on TV are affected directly by the ruling. This POV provides a brief summary of the background to this ruling, a summary of its specifics, some reactions to it, and our recommendations to clients in its wake.

Load More Posts